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Mutations in solute carrier family 9 isoform 6 on chromosome Xq26.3 encoding sodium–hydrogen exchanger 6, a protein mainly
expressed in early and recycling endosomes are known to cause a complex and slowly progressive degenerative human
neurological disease. Three resulting phenotypes have so far been reported: an X-linked Angelman syndrome-like condition,
Christianson syndrome and corticobasal degeneration with tau deposition, with each characterized by severe intellectual dis-
ability, epilepsy, autistic behaviour and ataxia. Hypothesizing that a sodium–hydrogen exchanger 6 deﬁciency would most likely
disrupt the endosomal–lysosomal system of neurons, we examined Slc9a6 knockout mice with tissue staining and related
techniques commonly used to study lysosomal storage disorders. As a result, we found that sodium–hydrogen exchanger 6
depletion leads to abnormal accumulation of GM2 ganglioside and unesteriﬁed cholesterol within late endosomes and lyso-
somes of neurons in selective brain regions, most notably the basolateral nuclei of the amygdala, the CA3 and CA4 regions and
dentate gyrus of the hippocampus and some areas of cerebral cortex. In these select neuronal populations, histochemical
staining for b-hexosaminidase activity, a lysosomal enzyme involved in the degradation of GM2 ganglioside, was undetectable.
Neuroaxonal dystrophy similar to that observed in lysosomal disease was observed in the cerebellum and was accompanied by a
marked and progressive loss of Purkinje cells, particularly in those lacking the expression of Zebrin II. On behavioural testing,
Slc9a6 knockout mice displayed a discrete clinical phenotype attributable to motor hyperactivity and cerebellar dysfunction.
Importantly, these ﬁndings show that sodium–hydrogen exchanger 6 loss of function in the Slc9a6-targeted mouse model leads
to compromise of endosomal–lysosomal function similar to lysosomal disease and to conspicuous neuronal abnormalities in
speciﬁc brain regions, which in concert could provide a uniﬁed explanation for the cellular and clinical phenotypes in humans
with SLC9A6 mutations.
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Introduction
The sodium–hydrogen exchanger (NHE) proteins belong to a large
family of transporters encoded by members of the solute carrier
(SLC) gene superfamily (He et al., 2009). Defects of one of these
transporters, sodium–hydrogen exchanger 6 (NHE6), encoded by
SLC9A6 at the locus Xq26.3 was ﬁrst detected in males with in-
tellectual disability, microcephaly, epilepsy, ataxia and behavioural
abnormalities mimicking Angelman syndrome (Gilﬁllan et al.,
2008). Following the identiﬁcation of other patients with
SLC9A6 mutations, three clinical phenotypes have emerged: ﬁrst,
the most common clinical manifestation to date appears to be an
X-linked Angelman syndrome-like condition; a second Angelman
syndrome-like phenotype, also known as Christianson syndrome
(OMIM #300243) (Christianson et al., 1999), which appears to
show a divergent phenotype in older patients (Gilﬁllan et al.,
2008; Schroer et al., 2010); ﬁnally, a third phenotype presents
with corticobasal degeneration and tau deposition and with
severe intellectual disability and autistic behaviour (Garbern
et al., 2010). Since SLC9A6 loss of function is an established
cause of neurodegenerative disease, our goal was to explore the
cellular mechanisms behind the degenerative process.
The NHE proteins are known to play an important role in the
ﬁne-tuning of organellar pH. Normally, a decrease of pH occurs
from cytosol (pH 7.2) to the early endosome (pH 6.3) and to the
lysosome (pH 4.7) [see Casey et al. (2010)]. As an evolutionarily
conserved mechanism for protection against excess acidiﬁcation,
cation–H
+ exchangers couple the transfer of H
+ across biological
membranes to the counter transport of monovalent cations such
as Na
+ or K
+. In order to carry out this task, mammals are known
to possess nine NHE isoforms, NHE1–9 (encoded by SLC9A1–9);
for a review see Oghaki et al. (2011). NHE1–NHE5 are believed to
be localized to the plasma membrane and NHE7 and NHE8 to the
Golgi and trans-Golgi network. NHE6 localizes to early and recy-
cling endosomes and transiently associates with the cell surface,
whereas NHE9 localizes mostly to late recycling endosomes
(Nakamura et al., 2005). Three important functions of the NHE6
protein have been suggested: pH regulation through its function
as a transporter of Na
+ in and H
+ out of the endosomal com-
partment; endosomal volume regulation; and regulation of the
rate of surface receptor recycling (Brett et al., 2002).
Given the putative role of NHE6 in early endosomal function,
we hypothesized that its absence might cause disturbances of
endosomal–lysosomal function, possibly leading to storage of ma-
terials within neurons. We therefore examined Slc9a6 knockout
mice with a panel of methods used to assess the consequences
of lysosomal dysfunction, including secondary accumulation of
glycolipids in the brain (Walkley, 1998; Walkley and Vanier,
2009). Here, we demonstrate that NHE6 depletion in mice leads
to abnormal accumulation of GM2 ganglioside and unesteriﬁed
cholesterol within late endosomes and lysosomes in neurons
within selective brain regions, most notably the amygdala and
CA3 and CA4 regions of the hippocampus, and to extensive de-
generation of cerebellar Purkinje cells. The cellular changes in neu-
rons were similar to those observed in various lysosomal disorders
and may explain both the pathological and clinical disease features
in humans with mutations in SLC9A6.
Materials and methods
Animals, messenger RNA assay and
tissue collection
All procedures were carried out in accordance with The Institutional
Animal Care and Use Committee of the Albert Einstein College
of Medicine. The Slc9a6 knockout mice (Stock# 005843, strain
name B6.129P2-Slc9a65tm1Dgen) were obtained from Jackson
Laboratories (see also JAX Mice Database). The model was engineered
by inserting the LacZ reporter gene, which encodes b-galactosidase
into the Slc9a6 genomic locus (Deltagen). Hemizygous Slc9a6
/X fe-
males were bred with wild-type Slc9a6
+/Y or hemizygous Slc9a6
/Y
males resulting overall in the production of wild-type Slc9a6
+/+,
hemizygous Slc9a6
/X and homozygous Slc9a6
/ females, and
hemizygous Slc9a6
/Y and wild-type Slc9a6
+/Y males
(Supplementary Fig. 1A). As the inserted LacZ-Neo cassette created
a larger polymerase chain reaction product, the genotyping was based
upon expected band sizes (Supplementary Fig. 1B) and inspection of
external genitalia at 2 weeks of gestation. In all experiments, male
Slc9a6
/Y and female Slc9a6
/ mice were used as mutants and
wild-type Slc9a6
+/Y males as controls. On average, four mice of
each genotype were used in each experiment.
The LacZ-Neo cassette inserted into exon 6 of Slc9a6 introduces a
stop codon and a polyadenylation termination signal. The expected
consequence of this manipulation would be termination of, or severely
reduced transcription behind, the LacZ-Neo cassette. We therefore
assayed the expression of various exons affected by the LacZ-Neo
cassette by quantitative real-time polymerase chain reaction on total
messenger RNA from wild-type and Slc9a6 mutant mice (Fig. 1A).
These methods are further detailed in the Supplementary material.
The primers are listed in Supplementary Table 1.
Mice used for tissue collection were deeply anaesthetized with
sodium pentobarbital (150mg/kg) and perfused transcardially with
0.9% saline followed by excision of the right cerebral hemisphere,
which was immediately frozen for biochemical analysis. Transcardial
ﬁxation perfusion was then performed using 4% paraformaldehyde
in 0.1M phosphate buffer. The remaining cerebral and cerebellar tis-
sues were excised and immersion ﬁxed overnight before being trans-
ferred to 0.1M phosphate buffer for storage at 4C.
Staining procedures
Antibodies and reagents used for staining procedures are included in
the Supplementary material.
3370 | Brain 2011: 134; 3369–3383 P. Strømme et al.Figure 1 Slc9a6 expression in the mouse brain. (A) Schematic drawing illustrating the insertion of the LacZ-Neo cassette into exon
6 and the positioning of the primers used in quantitative real-time polymerase chain reaction (Rt-PCR) to assay messenger RNA levels.
Asterisk = forward primer in exon 6 is within the deleted 847–898 region. (B) Real-time polymerase chain reaction on total RNA from
cerebral cortex demonstrated abundant messenger RNA obtained with all three primer sets in wild-type control mice (red bars). In the
female (green bars) and male (blue bars) mutants, a moderate but signiﬁcant reduction of transcription initiation is indicated by real-time
polymerase chain reaction with primer set 1, whereas messenger RNA from targeted exon 6 (primer set 2) is absent. Messenger RNA
containing exons 12–14 (primer set 3) is virtually absent in mutant mice. (C–H) Results of X-GAL staining revealing LacZ gene product
expression driven by the endogenous Slc9a6 promoter. (C) Coronal section of the brain of Slc9a6
/Y mouse at a level that includes the
hippocampus and the dorsolateral amygdala nucleus (a). Positive blue–green X-GAL staining reveals widespread expression in the brain,
particularly in neurons of the hippocampus. (D) Positive staining in the dentate gyrus of the hippocampus. (E) Dentate gyrus of the
hippocampus from wild-type used as a negative control shows absence of background staining after X-GAL incubation. (F and G)
Markedly positive X-GAL staining in the Purkinje cell layer of the cerebellum in a Slc9a6
/Y mouse. (H) Similar to E, wild-type
cerebellum shows absence of X-GAL reactivity.
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Free-ﬂoating sections were used for immunohistochemistry as
described previously (McGlynn et al., 2004; Sillitoe et al., 2008).
Brieﬂy, for immunoperoxidase labelling, sections were blocked for 1h
in 1% bovine serum albumin, 1.5% normal goat serum and 0.02%
saponin in phosphate-buffered saline. Tissue was next incubated with
primary antibodies in diluent (1% bovine serum albumin, 1% normal
goat serum, and 0.02% saponin in phosphate-buffered saline)
overnight at 4C. After washing, biotinylated secondary antibodies
were applied, followed by washing and incubation with
VECTASTAIN avidin and biotinylated horseradish peroxidase macro-
molecular complex (ABC) kit (Vector Laboratories). Sections were
then stained with 3,3-diaminobenzidine substrate kit for peroxidase
(Vector Laboratories) and further counterstained with Nissl before
mounting with Permount (Fisher). Immunoﬂuorescence labelling
included blocking for 1.5h with 1% bovine serum albumin,
10% normal goat serum and 0.02% saponin in phosphate-buffered
saline, followed by primary antibody application with 1% bovine
serum albumin, 5% normal goat serum and 0.02% saponin in
phosphate-buffered saline overnight at 4C. Incubation with ﬂuores-
cent secondary antibodies was followed by tissue mounting using
Prolong Antifade reagent (Invitrogen). Filipin labelling of unesteriﬁed
cholesterol was performed by incubating pre-washed tissue sections in
the working solution for 20 min. 5-Bromo-4-chloro-3-indolyl-b-D-
galactopyranoside (X-GAL) was used to detect LacZ transgene expres-
sion. A 40mg/ml X-GAL stock solution was diluted to 1mg/ml work-
ing concentration in reaction buffer (5mM potassium ferricyanide,
5mM potassium ferrocyanide and 2mM magnesium chloride in
10mM phosphate-buffered saline, pH 7.2, at room temperature).
Tissue sections were cut at 40mm and washed in cold
phosphate-buffered saline, followed by washes with reaction buffer.
Sections were then incubated in reaction mixture containing X-GAL at
37C for 3h, followed by washes with cold phosphate-buffered saline.
Mounting was done directly onto gel-coated slides using 10%
phosphate-buffered saline/90% glycerol. For the analysis of cerebellar
compartmentalization serial, 40-mm thick coronal sections were cut on
a cryostat (Leica CM3050) and collected as free-ﬂoating sections in
phosphate-buffered saline. Immunohistochemistry was carried out
similar to that previously described. Brieﬂy, tissue sections were
washed thoroughly, blocked with 1.5% normal goat serum for 1h
at room temperature and then incubated in 0.1 M phosphate-buffered
saline buffer containing 0.1% Triton-X and primary antibodies for
16–18h at room temperature. Tissue sections were then washed
three times in phosphate-buffered saline and incubated in secondary
antibodies for 2h at room temperature. After three ﬁnal rinses in
phosphate-buffered saline, the tissue sections were mounted on elec-
trostatically coated slides and coverslipped using Fluoro-Gel (Electron
Microscopy Sciences).
Saline perfused, rapidly frozen cerebral hemispheres from Slc9a6
/Y
versus Slc9a6
+/Y mice were also analysed biochemically to quantita-
tively analyse the expression of GM2, GM3 and related gangliosides
using methods identical to those published recently (Micsenyi et al.,
2009; Zhou et al., 2011). Additionally, western blots were performed
to analyse for the presence of hyperphosphorylated tau. The method-
ology for the western blot procedures is provided in the
Supplementary material.
For histochemical detection of lysosomal b-hexosaminidase
(E.C. 3.2.1.52), freshly cut 40mm thick vibratome sections from 4%
paraformaldehyde-ﬁxed tissue were assayed with 5-bromo-4-chloro-3-
indolyl-N-acetyl-b-D-glucosaminide (X-HEX) (Research Organics
#1175B). Free-ﬂoating sections were incubated for 19h at 37C
with 2.5mg/ml X-HEX (from a 40mg/ml stock in dimethylsulphoxide)
in 0.1M citric acid/0.2M sodium phosphate buffer, pH 4.5, containing
0.5mM potassium ferrocyanide and 0.5mM potassium ferricyanide.
The reaction was terminated on ice by washing ﬁrst with cold 0.1
M citric acid/0.2M sodium phosphate buffer alone, followed by ﬁve
washes in 0.15M phosphate-buffered saline, pH 7.4. Sections were
mounted with 10% phosphate-buffered saline/90% glycerol and
sealed with nail hardener.
Tissue imaging and nomenclature
Wideﬁeld microscopy was carried out using either a Leica DM5500
microscope running Leica LAS-AF software (Leica DFC360 FX) for
cerebellar patterned Purkinje cell loss studies or an Olympus AX70
upright epiﬂuorescence microscope equipped with a MagnaFire CCD
camera (Optronics) for all other studies. Confocal ﬂuorescence imaging
was performed using a Zeiss Meta Duo V2 laser scanning confocal
microscope. Immunoﬂuorescence images were acquired with a 63
(1.4 numerical aperture) oil objective. All raw data were imported into
Adobe Photoshop CS4 and adjusted for brightness and contrast, and
occasionally for colour. The nomenclature and labelling of subnuclei of
the amygdala complex were adopted from Paxinos and Watson
(1986). The cerebellar lobules were indicated by Roman numerals ac-
cording to Larsell (1952), cerebellar stripe nomenclature was according
to Sillitoe and Hawkes (2002) and the cerebellar transverse zones were
labelled according to Ozol et al. (1999).
Electron microscopy
Brain tissue for electron microscopy was prepared as previously
described (Micsenyi et al., 2009). Following ﬁxation of tissue described
above, blocks for electron microscopy were post-ﬁxed in 2.5% glutar-
aldehyde in 0.1M cacodylate buffer then rinsed in 0.1 M cacodylate
buffer. Samples were next incubated in 1% osmium tetroxide in 0.1 M
cacodylate buffer, followed by dehydration in graded alcohols and
acetonitrile. Blocks were inﬁltrated overnight in 1:1 EPON
TM/acetoni-
trile, followed by inﬁltration and embedding with whole EPON
TM.
Sections were then cut with an ultramicrotome and stained with
uranyl acetate and lead citrate. In some cases, vibratome sections
were treated with antibodies to GM2 ganglioside and processed for
peroxidase labelling, followed by EPON
TM embedding and sectioning
as described. Electron microscopy was performed using a Philips CM10
electron microscope.
Behavioural studies
Only male Slc9a6
/Y (n=6) and male wild-type Slc9a6
+/Y (n=10)
mice were used for behavioural assays. Open ﬁeld activity was as-
sessed using Viewer Software (Bobserve) in a 39  39cm arena for
6 min with the middle of the body of the animal deﬁned as the criteria
point for tracking and zone entry. Locomotor activity was assessed as
the total track length and exploration by the number of rears (scored
manually). Anxiety-like behaviour (thigmotaxis) was assessed by cen-
tral zone exploration (number of entries, centre track length and dur-
ation of time spent in the centre) (Choleris et al., 2001). The central
zone was deﬁned as a 15  15cm area in the centre of the box.
Motor coordination was assessed in the balance beam assay as the
latency to cross a round beam (1.5cm diameter) and number of slips
made while crossing (Stanley et al., 2005). To minimize variation and
acclimatize mice to the task, mice were ﬁrst pre-trained to walking
over a ﬂat wooden plank (6cm wide) with a brightly lit start area and
a goal box with a hide containing a palatable food (cocoa crispy) until
they reliably and readily crossed the plank (two or three trials).
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phobia. Methods used for testing spatial memory in the object place-
ment task (Ennaceur and Meliani, 1992) are detailed in the
Supplementary material. Behavioural assays were analysed with
one-way ANOVA tests. P-values 0.05 were considered to be statistic-
ally signiﬁcant.
Web resources
Alan Institute for Brain Science: http://mouse.brain-map.org/
welcome.do
Deltagen: http://www.informatics.jax.org/external/ko/deltagen/1688_
MolBio.html
Jackson laboratories: http://jaxmice.jax.org/protocolsdb/
JAX Mice Database B6.129P2-Slc9a6
tm1Dgen/J: http://jaxmice.jax.org/
strain/005843.html
Online Mendelian Inheritance in Man (OMIM): http://www.ncbi.nlm.
nih.gov/Omim
Results
Tissue Slc9a6 expression
Quantitative real-time polymerase chain reaction at the Slc9a6
targeted loci demonstrated successful transcription termination in
cerebral cortex (Fig. 1A and B) in Slc9a6
/Y and Slc9a6
/ mice
as a result of the tm1 termination region inserted after the
LacZ-Neo gene. Abundant full-length Slc9a6 messenger RNA
was detected in cerebral cortex from wild-type mice. Intense posi-
tive X-GAL staining, indicating the presence of targeted Slc9a6,
was observed not only in the molecular layer of the cerebellum
and hippocampus, but also in the cortical and subcortical regions,
including the amygdala (Fig. 1C–H). This correlated with the
genome-wide atlas of gene expression in the adult mouse brain
(Lein et al., 2007); see also http://mouse.brain-map.org/welcome.
do.
Cellular pathology
Histopathological examination of brain for evidence of disturb-
ances of lysosomal function revealed regional accumulation of
GM2 ganglioside in mutant mice (Fig. 2). The staining in wild-type
littermate age-matched controls showed absent to rarely occurring
positive granules (Fig. 2C, F and G) as previously reported
(Goodman and Walkley, 1996). GM2 ganglioside accumulation
was particularly prominent in the basolateral nuclei of the amyg-
dala complex. Especially in Slc9a6
/ (female) mice, affected neu-
rons in mice as young as 8 weeks exhibited large amounts of
densely stained material (Fig. 2A and B). GM2 ganglioside was
also present in several of these same nuclei of the amygdala of
Slc9a6
/Y (male) mice, but the staining here was less intense (data
not shown). By 12 weeks of age, GM2 ganglioside-accumulating
neurons were also observed in the CA3 and CA4 regions and the
inner dentate gyrus of the hippocampus (Fig. 2D and E), as well as
hypothalamus, fasciola cinereum and piriform cortex. The number
and intensity of GM2 ganglioside-labelled cells observed was typ-
ically greater in older Slc9a6 mutant mice compared with younger
mutants. We also stained brain tissues for GM1, GM3 and GD3
gangliosides, and analysed brains biochemically for ganglioside ex-
pression levels, but found no differences between Slc9a6 mutant
mice and wild-type.
We examined tissues for activity of the lysosomal enzyme
responsible for GM2 degradation (b-hexosaminidase) using an
X-HEX histochemical reaction, in which this substrate when
cleaved, forms an insoluble blue–green product at the site of
enzyme activity. Remarkably, we found little to no evidence of ac-
tive enzyme in neurons storing GM2 ganglioside (Fig. 3B and D),
whereas comparable wild-type neurons showed robust staining
(Fig. 3A and C). To determine whether the accumulated GM2
ganglioside was interfering with the histochemical stain, we also
stained these same brain areas in mice with Niemann–Pick disease
type C, which have normal b-hexosaminidase activity and also
signiﬁcant intraneuronal GM2 ganglioside accumulation (Walkley
and Suzuki, 2004) and found levels of X-HEX staining comparable
with wild-type (data not shown). We also performed X-HEX stain-
ing in mice with Sandhoff disease (OMIM #268800) caused by
total b-hexosaminidase deﬁciency and as expected found no
X-HEX staining (data not shown). Comparison of the degree of
staining for LAMP2 and cathepsin D (data not shown) speciﬁcally
in the CA3 and CA4 regions and the dentate gyrus of the hippo-
campus also revealed detectably greater staining in the Slc9a6
mutant mice than in wild-type, consistent with an enhancement
of the number of lysosomes in these neurons (Fig. 3E and F).
Filipin labelling in Slc9a6
/ mice demonstrated detectable
amounts of unesteriﬁed cholesterol in cells of the basolateral
amygdala in a manner similar to that observed for GM2 ganglio-
side (Fig. 4). As expected, and consistent with the earlier published
data (Walkley and Vanier, 2009), neurons of wild-type mice
showed no evidence of positive labelling with ﬁlipin (data not
shown). Confocal microscopy of sections double labelled for
GM2 ganglioside and unesteriﬁed cholesterol showed that in the
amygdala, cholesterol and GM2 ganglioside, sequestration
occurred in the same neurons but that the two substrates were
largely segregated to different subcellular vesicular populations
(Fig. 4A–C). Importantly, when GM2 ganglioside staining was
combined with LAMP2 in immunoﬂuorescence studies and
analysed by confocal microscopy, the vast majority of the two
markers was co-localized (Fig. 4D–F), indicating that the ganglio-
side accumulation occurred speciﬁcally in late endosomes and
lysosomes. Cholesterol was also principally localized to LAMP2-
positive vesicles (data not shown).
Considering the report by Garbern et al. (2010) that human
SLC9A6 mutations were characterized by tau deposition in brain,
western blots were performed to determine whether changes
could be detected in phosphorylated tau in brains of Slc9a6 mu-
tants. As shown in Supplementary Fig. 2, small elevations in
hyperphosphorylated tau were found in soluble brain fractions in
both hemizygous male and homozygous female Slc9a6 mutant
mice compared with age-matched wild-type.
Electron microscopy studies were also carried out on cerebral
cortex, amygdala and cerebellum and several abnormalities and
unusual features were observed in Slc9a6 mutant mice. The cyto-
plasm of some neurons in the amygdala exhibited singular,
non-membrane-bound structures resembling aggresomes (Fig. 5A
and B), or one or more membrane-bound lysosomal-like inclusions
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the amygdala and cerebral cortex, both with and without the in-
clusions indicated above, also exhibited an abnormal distribution of
vesicular organelles with these appearing corralled near the Golgi
and trans-Golgi network with other perikaryal regions appearing
organelle deﬁcient (Fig. 5E and F). Notably, neurons of the amyg-
dala in mice exhibiting robust GM2 ganglioside storage typically
contained multiple, large (0.5–1.0mm diameter) loose-lamellar
vesicles resembling storage bodies observed in some lysosomal dis-
eases (Fig. 5G and H). The use of peroxidase-based immuno-
electron microscopy conﬁrmed that these vesicles were the sites
of GM2 ganglioside storage (Fig. 5H, inset). In addition to these
changes, nuclei of neurons in the amygdala and elsewhere were
often lobulated excessively and/or their nucleoli were multiple in
number and conspicuous by their electron density. In contrast to
these ﬁndings in cerebral cortex and subcortical regions, electron
Figure 2 Immunostaining for GM2 ganglioside in 3-week and 8-week old Slc9a6
/ (female) mice. (A) At 3 weeks of age, prominent
accumulation of GM2 ganglioside was observed in the anterior part of the basolateral amygdala. (B) At higher magniﬁcation, dense
vesicular labelling occurred in individual neuronal cell bodies. (C) Immunoreactivity in the amygdala in an age-matched wild-type mouse
from the same litter is near absent. (D and E) Accumulation of GM2 ganglioside was also seen in neurons of the CA3 and CA4 regions of
the hippocampus of a Slc9a6
/ mouse at 8 weeks of age, as well as in the cell bodies of neurons in the dentate gyrus. (F and G) No GM2
immunoreactivity was found in these same regions of the hippocampus in an aged-matched wild-type mouse. Scale bars: A = 500mm;
B and C =2 5mm; D and F = 200mm; E and G =4 0mm.
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evidence of a lysosomal storage process.
Purkinje cell loss
The extensive and progressive loss of Purkinje cells observed in the
cerebellum of Slc9a6 mutant mice is illustrated in Fig. 6. Another
striking feature was the presence of Purkinje cell axonal spheroids
(Fig. 6C and E). The spheroids appeared similar to those observed
in a number of lysosomal disorders, including Niemann–Pick dis-
ease type C (Walkley et al., 2010). The loss of Purkinje cells was
not random but instead occurred in a regular pattern of parasag-
ittal stripes in the cerebellar vermis (Figs 7, 8A and B) and hemi-
spheres (Fig. 8C). Patterned Purkinje cell loss was reminiscent of
the compartmentalized expression of proteins such as Zebrin II/
Aldolase C (Ahn et al., 1994; Sillitoe and Hawkes, 2002). It is well
known that Purkinje cells express many genes in a complex array
of stripes that are unique to subsets of lobules (Sillitoe and Joyner,
2007). For example, Zebrin II is expressed in an array of stripes in
lobules I–V and VIII, whereas the small heat shock protein 25
(HSP25) is expressed in stripes selectively in lobules VI/VII and
IX/X. In contrast, Calbindin is expressed in all Purkinje cells and
can be used to determine the extent of Purkinje cell degeneration
in the cerebellum. We found in Slc9a6
/Y mice that loss of
calbindin-expressing Purkinje cells occurred ﬁrst within Zebrin
II-negative stripes, whereas Purkinje cells in the Zebrin II-positive
stripes were more resistant to the degenerative process (Fig. 7A–F).
Purkinje cells in lobules VI/VII and IX/X, which express Zebrin II
uniformly, were most resistant to neuronal degeneration (Fig. 8C).
Interestingly, the general pattern of Purkinje cell stripe degener-
ation in Slc9a6
/Y mice was similar to the pattern of degen-
eration previously reported in Niemann–Pick disease type C mice
(Sarna et al., 2003). No obvious cell loss was detected in the
cerebrum by light microscopy. This applied also to the amygdala
and other areas in the cerebrum affected by GM2 ganglioside
accumulation.
Figure 3 Histochemical staining to reveal b-hexosaminidase activity. (A and C) X-HEX staining in brain tissue from wild-type is robust as
evidenced by blue/green labelling. (B and D) Slc9a6
/ mice show absent or greatly diminished X-HEX staining in the dentate gyrus
(compare boxes in A and B which are enlarged as C and D, respectively) and in the CA3 and CA4 regions of the hippocampus (arrows in A
and B). (F and E) LAMP2 (as well as cathepsin D, data not shown) staining performed to assess the extent of lysosomal involvement
showed more intense labelling in the Slc9a6
/ mutant hippocampus (F) than in the wild-type (E). E and F represent areas of the dentate
gyrus equivalent to those shown in C and D. Scale bars: A and B = 400mm; C–F =2 0mm.
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In the open ﬁeld, Slc9a6
/Y mice demonstrated a longer total
track length (Fig. 9A) and a higher number of rears (Fig. 9B),
both interpreted as a sign of modest but signiﬁcant motor hyper-
activity. There were no indications of differences in anxiety-like
behaviour in the open ﬁeld, as assessed by thigmotaxis
(Supplementary Table 2). Motor coordination deﬁcits were evident
in the balance beam test as the mutants had a higher number of
slips (Fig. 9C) and longer latency time to cross the beam (Fig. 9D).
Gross ataxia, however, was not evident in Slc9a6
/Y mice in spite
of the loss of many Purkinje cells, possibly reﬂective of other parts
of the motor system being intact. In the object placement test of
spatial memory, both mutants and wild-type mice could perform
the task equivalently with a 20-min retention interval.
Genotype–phenotype correlation
In most cases, the Slc9a6 mutant mice were not associated with
an obvious clinical phenotype on simple clinical inspection, al-
though mild motor hyperactivity and deﬁcits in motor coordination
were evident in older mice when speciﬁc behavioural tests were
applied to Slc9a6
/Y males (Fig. 9). In some Slc9a6
/ mice,
but not all, we observed premature death 3 weeks of age. The
Slc9a6
/ genotype seemed to coincide with more pronounced
GM2 ganglioside accumulation in affected neurons. This increased
sensitivity to Slc9a6 loss of function in the female mouse brain could
be due to stochastic events in our study and not necessarily genetic
predetermination. Occasionally in X-linked disorders, an exaggerated
phenotype is known to segregate with homozygous females, as has
been reported in Retinoschisis (OMIM #312700) (Ali et al., 2003).
In human disease, the female homozygous state occurs rarely as it
requires intermarriage. Unprovoked clinical seizures were not
observed in Slc9a6
/ or Slc9a6
/Y mice.
Discussion
Our data indicate that Slc9a6 loss of function leads to altered
endosomal–lysosomal function in many neurons as evidenced by
the accumulation of GM2 ganglioside and cholesterol. The loss of
Purkinje neurons, while not linked here to any evident changes
in endosomes or lysosomes within Purkinje cell somata, is none-
theless remarkably similar to the degenerative events that charac-
terize cerebellar pathology in many lysosomal diseases. In human,
SLC9A6 mutation symptoms are usually not obvious at birth, but
may present within the ﬁrst year as developmental delay, seizures,
ataxia, motor hyperactivity and stereotypies, and sometimes easily
Figure 4 Confocal microscopy of GM2 ganglioside and cholesterol staining in neurons of the basolateral amygdala in a 3-week old
Slc9a6
/ (female) mouse. (A–C) Combined GM2 ganglioside immunoﬂuorescence and ﬁlipin labelling for cholesterol reveal that both
substrates are sequestered in the same neurons but are largely not co-localized to the same vesicles. (D–F) Combined GM2 ganglioside
and LAMP2 immunoﬂuorescence demonstrate that the GM2 ganglioside accumulation is typically localized to LAMP2-positive late
endosomes and lysosomes. Scale bars = 5mm; n = nucleus.
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Angelman syndrome (Williams et al., 2006).
Solute carrier transporters are believed to play essential roles in
cellular uptake and efﬂux of nutrients, neurotransmitters, metab-
olites and electrolytes (He et al., 2009). Several of these transport-
ers have been associated with inherited metabolic disease
(Bergeron et al., 2008). In mouse, intricate solute carrier expres-
sion patterns associated with neuroanatomical organization have
been observed (Dahlin et al., 2009). In the present study, we have
documented widespread tissue expression of NHE6 throughout the
cerebrum and cerebellum (Fig. 1C–H). The extent of NHE6 expres-
sion did not, however, coincide with those areas that seemed most
vulnerable to develop tissue pathology such as the amygdala and
CA3 and CA4 regions of the hippocampus. In the basolateral
nuclei of the amygdala, NHE6 expression was not especially con-
spicuous, yet this was the site of massive GM2 ganglioside accu-
mulation. Strong NHE6 tissue expression in the Purkinje cell layer
of the cerebellum (Fig. 1F and G) coincided with Purkinje cell loss
(Fig. 6), but without abnormal GM2 ganglioside accumulation or
related evidence of endosomal or lysosomal dysfunction.
Evidence of endosomal–lysosomal
dysfunction
Storage involving late endosomes and lysosomes of neurons and
glia are a hallmark of most lysosomal diseases (Walkley, 1998,
2004a). In the present study, the accumulation of GM2 ganglio-
side was found to occur in abundance in neurons of select brain
regions such as the amygdala and hippocampus and was localized
principally to LAMP2-positive vesicles (Fig. 4), the staining for
which was also increased in these areas (Fig. 3F). Remarkably,
GM2-accumulating neurons also exhibited little or no evidence
of activity of the GM2-degradative lysosomal hydrolase,
b-hexosaminidase (Fig. 3B and D). While this ﬁnding provides a
straightforward explanation for the increase in GM2 ganglioside,
understanding why an NHE6 deﬁciency leads to such an effect,
and why it exhibits such striking neuron type-speciﬁcity, are un-
known and will require further investigation.
In human brain, GM2 and GM3 gangliosides are normally very
minor components and constitute no more than 1–2% of the total
amount of gangliosides. Their proportion is even smaller in normal
mouse brain. Sequestration of GM2 ganglioside is observed in
many lysosomal diseases, most notably in GM2 gangliosidosis,
and also in diseases without known defects in glycosphingolipid
catabolism, such as Niemann–Pick disease type C and many of the
mucopolysaccharidoses (McGlynn et al., 2004; Walkley, 2009;
Walkley and Vanier, 2009). This ﬁnding has led to the view that
this ganglioside, along with GM3 ganglioside, represents sensitive
markers of endosomal–lysosomal dysfunction (Walkley, 2004b). In
the current study, biochemical analysis did not reveal increases in
either total GM2 or GM3 gangliosides, but immune labelling clear-
ly showed selective accumulation of GM2 ganglioside in neurons.
Given the highly localized nature of this accumulation, it is not
Figure 5 Electron microscopy studies of neurons in the amygdala of a 19-day-old Slc9A6
/(female) mouse. (A) Neuron exhibiting a
large non-membrane bound body resembling an aggresome (higher magniﬁcation shown in B). (C) Neuron exhibiting conspicuous double
nucleolus and dispersed cytoplasm as well as a membrane-bound inclusion containing a dense storage matrix (higher magniﬁcation shown
in D). (E) Neuron exhibiting a heavily lobulated nucleus and a collection of vesicular and other structures corralled near the Golgi and
trans-Golgi network (higher magniﬁcation shown in F). (G) Neuron exhibiting conspicuous loose lamellar inclusions that by immunoe-
lectron microscopy (higher magniﬁcation in H) were shown to exhibit GM2 ganglioside positivity. Scale bar = 1.9mm( A), 0.5mm( B),
4.0mm( C), 1.0mm( D), 3.15mm( E), 1.4mm( F), 1.6mm( G), 1.0mm( H) and 1.0mm (inset, H).
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reveal signiﬁcant differences. In terms of cholesterol, total brain
levels are not typically increased in various lysosomal diseases, but
conspicuous sequestration of unesteriﬁed cholesterol does often
occur in individual brain cells, for example in GM2 gangliosidosis
and in Niemann–Pick disease type C (Walkley and Vanier, 2009).
Cholesterol sequestration is thus another likely indicator of a pro-
cessing defect in the endosomal–lysosomal system (Walkley and
Vanier, 2009). The Slc9a6 mutant mice were no exception in that
unesteriﬁed cholesterol often was found in the same neurons stor-
ing GM2 ganglioside. However, just as observed in lysosomal dis-
eases (McGlynn et al., 2004; Zhou et al., 2011) the accumulating
cholesterol and GM2 ganglioside, while both found in
LAMP2-positive vesicles, were not typically co-localized. This ﬁnd-
ing is believed to be indicative of the heterogeneity of processing
within the endosomal–lysosomal system (Zhou et al., 2011). These
ﬁndings provide further support for the view that Slc9a6 defects
cause disturbances in endosomal–lysosomal processing, which in
turn leads to the accumulation of substrates in late endosomes and
lysosomes in a manner typical of many lysosomal disorders.
Furthermore, while many lysosomal diseases exhibit widespread
neuronal involvement, others exhibit storage restricted to select
neuronal populations (Walkley, 1998, 2004a, b) in a manner not
dissimilar to ﬁndings here in Slc9a6 deﬁciency. It is likely that
endosomal compromise in NHE6-depleted mice is caused by
increased intravesicular acidity. However, in HeLa cells, depletion
Figure 6 Extensive and progressive loss of Purkinje cells in the mouse cerebellum. (A–C) Immunoperoxidase staining for calbindin (brown)
with Nissl counterstain (blue) revealed normal cerebellar Purkinje cells in a 19-day-old (p19) Slc9a6
/Y animal. The arrows in C indicate
axonal spheroids. (D) Purkinje cell degeneration, particularly noticeable in lobules I/II and III at p57. (E) Purkinje cell loss and axonal
spheroids (encircled) at p57. (F) Purkinje cell that has lost all dendritic branches (ML = molecular layer; PCL = Purkinje cell layer;
GCL = granular cell layer). (G) Purkinje cell degeneration is extensive with relative sparing of lobules IX and X at p153. (H) Purkinje cells in
the process of losing dendritic branches. (I) Magniﬁed view of insert in G.
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/Y mice. (A) Zebrin II is expressed in parasagittal stripes of
Purkinje cells. (B) Calbindin is expressed in all Purkinje cells. (C) Merged image of A and B.( D) Zebrin II expression is normal in Slc9a6
/Y
mice. (E) Calbindin expression reveals patterned Purkinje cell degeneration in Slc9a6
/Y mice. (F) Merged image of D and E illustrating
that all surviving Purkinje cells in Slc9a6
/Ymice are Zebrin II immunoreactive (see P1 and P3 stripes and white arrows). Lobules are
indicated by Roman numerals according to the previous nomenclature. Scale bar: A = 500mm.
Figure 8 Purkinje cell degeneration was patterned in the cerebellar vermis and hemispheres of Slc9a6
/Ymice. (A) Calbindin is expressed
in all Purkinje cells in wild-type mice. (B) Calbindin expression reveals parasagittal stripes in the vermis (red arrows) and hemispheres
(red asterisks) of Slc9a6
/Ymice. (C) Low power image of an Slc9a6
/Yanimal illustrating: (i) the parasagittal pattern of surviving Purkinje
cells in the hemispheres (each stripe is labelled with a red asterisk); and (ii) Purkinje cells in the central zone (CZ, lobules VI/VII) and nodular
zone (NZ, lobules IX/X) are resistant to degeneration (white brackets). Scale bar: C = 1mm (=500 mm for A and B). Cop = copula
pyramidis; Pmd = paramedian lobule.
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pH, whereas co-depletion of NHE6 and NHE9 caused enhanced
acidiﬁcation in early endosomes (Roxrud et al., 2009).
Electron microscopy data (Fig. 5) show evidence of accumulat-
ing materials within vesicles, as well as possible alterations in a
variety of cytoplasmic constituents and further support our
contention that Slc9a6 knockout causes disruption of the endoso-
mal–lysosomal system. Overall, neurons were found to contain
occasional dense, membrane-bound aggregates of material or
larger non-membrane-bound structures resembling aggresomes
(Johnston et al., 1998) or stigmoid bodies (Fujinaga et al.,
2009). The membrane-bound GM2 ganglioside-containing lyso-
somal storage body-like vesicles (Fig. 5H, inset) that were con-
spicuous in neurons of the amygdala resembled somewhat the
concentric multi-lamellar bodies found in some primary ganglioside
storage diseases, but not the zebra body characteristic of GM2
ganglioside storage, as for example observed by Stromme et al.
(1997) or in the mucopolysaccharidoses (McGlynn et al., 2004).
Neurons also exhibited unusual alterations in perikaryal distribution
of organelles, with some areas near the Golgi and trans-Golgi
network showing corralled groups of vesicles and other structures
(Fig. 5). Some neuronal nuclei were also heavily lobulated or con-
tained unusually conspicuous nucleoli. Additional electron micros-
copy studies are warranted to determine the full extent of the
impact of NHE6 deﬁciency on neurons.
Deterioration of organ system functioning is common in lyso-
somal storage diseases. Although deterioration in clinical status
was not observed in our Slc9a6
/Y mice, the extensive loss of
Purkinje cells in these mice correlates with cerebellar atrophy
observed in human SLC9A6 mutation (Gilﬁllan et al., 2008;
Schroer et al., 2010). Autopsies of several patients with SLC9A6
mutations have demonstrated marked neuronal loss and gliosis of
the globus pallidus, putamen, substantia nigra and cerebellar
cortex associated with tau-containing ﬁlaments on ultrastructural
examination (Garbern et al., 2010). The latter ﬁnding was believed
to be evidence of abnormal vesicular targeting secondary to NHE6
loss. Based on these studies, we also analysed the Slc9a6 mutant
mice for accumulation of phosphorylated tau, and found small
increases in the soluble brain fractions of mutant mice
(Supplementary Fig. 2). Interestingly, in Niemann–Pick disease
type C, storage of cholesterol and glycosphingolipids in the
human disease is consistently accompanied by the presence of
hyperphosphorylated tau and neuroﬁbrillary tangles. The mouse
model of Niemann–Pick disease type C, however, exhibits only
minor tau hyperphosphorylation and no evidence of a frank tauo-
pathy (Walkley and Suzuki, 2004). It is thus conceivable that the
tau depositions identiﬁed in human brains with SLC9A6 mutations
(Garbern et al., 2010) are a downstream consequence of endoso-
mal–lysosomal dysfunction just as they appear to be in human
Niemann–Pick disease type C. Interestingly, some forms of
Alzheimer’s disease have also recently been reported to exhibit
compromise in endosomal–lysosomal function with such abnorm-
alities likely being primary contributors to the brain pathology
(Lee et al., 2010).
Figure 9 Behavioural studies. Hyperactivity in the open ﬁeld in Slc9a6
/Y mice was demonstrated by (A) the signiﬁcantly higher track
length (P = 0.008) and (B) a signiﬁcantly increased number of rears (P = 0.03). Motor coordination deﬁcits in the Slc9a6
/Ymice were
evident in the balance beam as (C) signiﬁcantly higher number of slips (P50.001) and (D) a longer latency to cross the beam (P50.001).
Asterisk denotes statistically signiﬁcant difference.
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While some lysosomal diseases show more storage of GM2 gan-
glioside in certain groups of neurons, the singularly abundant level
of sequestration observed in amygdala in Slc9a6-targeted mice is
highly unusual. The amygdala complex is a collection of associated
nuclei along an anterior–posterior axis in the human temporal
lobe. The basolateral nuclei of the amygdala connect primarily
with thalamus and regions of the neocortex and send efferent
ﬁbres to the hippocampus (Manns and Eichenbaum, 2008).
These nuclei are the main route by which sensory information
enters the amygdala and its circuitry is just beginning to be eluci-
dated (Spampanato et al., 2011). In our study, we observed that
GM2 ganglioside accumulation was greatest by far in the medial
parts of the basolateral nuclei, but why such select neuronal in-
volvement occurred is unknown. Interestingly, GM2 ganglioside
accumulation was also noted in hippocampal CA3 and CA4 and
dentate gyrus neurons, and neurons of the piriform (entorhinal)
cerebral cortex and the fasciola cinereum, all of which represent
primitive archicortical and paleocortical brain regions.
In humans, lesions in the amygdala may cause impairment of
memory, emotions and learning and its dysfunction is also asso-
ciated with autism (Mosconi et al., 2009). The autistic-like behav-
iour caused by SLC9A6 mutation is comparable with that of Rett
and Angelman syndromes. Thus, MECP2, UBE3A and SLC9A6 are
all regarded as autism-related genes (Sutcliffe, 2008). In mice,
Mecp2 plays a key role as a transcriptional repressor in the baso-
laterol nuclei of the amygdala, mediating the behavioural features
of Rett syndrome (Adachi et al., 2009). Interestingly, a mutation
in SLC9A9 was shown to cause autism and seizures in humans
(Morrow et al., 2008; Sutcliffe, 2008). SLC9A9 is also a suscepti-
bility gene for hyperactivity attention deﬁcit disorders (de Silva
et al., 2003; Lasky-Su et al., 2008; Markunas et al., 2010).
Data on Slc9a9 knockouts are unavailable, so we do not know
if loss of NHE9 also leads to endosomal–lysosomal disruption in
the amygdala.
The amygdala and the cerebellum are involved in the neural
control of laughter (Parvizi et al., 2007), two anatomical areas
that conspicuously are targeted by NHE6 loss of function. Few
metabolic diseases are known to show strong predilection for
the amygdala. However, an exception is Urbach–Wiethe disease
(OMIM #247100), a putative lysosomal disease that particularly
may involve the amygdala and is associated with neuropsychiatric
symptoms (Goncalves et al., 2010).
Cerebellar degeneration
We have found a number of pathological defects in the cerebel-
lum of Slc9a6-targeted mice. Purkinje cell axons exhibited axonal
spheroids (Fig. 6C and E) that are swellings on the axon, typically
seen in Niemann–Pick disease type C and many other lysosomal
diseases (Walkley et al., 2010). The loss of Purkinje cells occurred
in parasagittal stripes (Fig. 7). This is not the ﬁrst demonstration
of patterned cell loss in the cerebellum. For example, in the spon-
taneous mutants ‘Nervous’, ‘Purkinje cell degeneration’ and
‘Tambaleante’, the patterns of surviving Purkinje cells were
arranged according to different and reproducible arrays of sagittal
bands that were symmetric about the midline (Wassef et al.,
1987). In addition, a parasagittal pattern of cell loss/survival was
also described in Niemann–Pick disease type C 1 mutant mice
(Sarna et al., 2003), and similar loss of Purkinje cells has been
observed in other lysosomal diseases (Walkley et al., 2010). The
pattern of cell death in our Slc9a6 mutants corresponded to
Niemann–Pick disease type C1 mice and was complementary to
the pattern reported in Nervous cerebella (Wassef et al., 1987).
Therefore, depending on the mutation, the surviving cells are
either Zebrin II-immunopositive or Zebrin II-immunonegative.
These data suggest that although Purkinje cells are differentially
sensitive to genetic defects, different mutations can lead to a fun-
damental pattern of cell death with topographical features that
respect the normal pattern of cerebellar gene expression.
Angelman syndrome—pathways
to intellectual disability
Most cases of Angelman syndrome are due to defects in UBE3A
encoding E6-AP, an E3 ubiquitin ligase that functions in the ubi-
quitin–proteasome system (Scheffner et al., 1993), a key cellular
mechanism for cytosolic protein degradation. Similarities in the
profound intellectual disability and related Angelman syndrome
features linked to both UBE3A and SLC9A6 mutations could be
explained if each protein coded for was integrated within the
same intracellular machinery for protein degradation, or if they
shared parallel functions in a key mechanism underlying learning
and memory. Indeed, this may be the case in terms of the exci-
tatory glutamatergic receptors at dendritic spine synapses. AMPA
(-amino-3-hydroxy-5-methylisoazole-4-proprionic acid) receptors
regulate the majority of fast excitatory neurotransmission and are
known to undergo rapid constitutive internalization as a conse-
quence of synaptic activity. This turnover or ‘cycling’ of AMPA
receptors is known to play a critical role in synaptic plasticity
(Isaac et al., 2007). Recent studies have indicated that prote-
asomes are present in dendritic spines, where they are believed
to function in synaptic development and plasticity (Patrick, 2006).
It is also well documented that ubiquitination and proteasomal
function play a critical role in endocytosis and signalling
(Mukhopadhyay and Riezman, 2007) including removal of surface
AMPA receptors (Turrigiano, 2002). However, another mechanism
governing synaptic plasticity is through neurotransmitter receptor
insertion and removal, followed by reinsertion or degradation, as
carried out by endosomes (Carroll et al., 2001). Once internalized,
AMPA receptors are sorted from early endosomes to either spe-
cialized recycling endosome for re-insertion in the plasmalemma
or, are trafﬁcked to the endosomal–lysosomal system for degrad-
ation. Thus, it will be important to determine whether defects in
E6-AP and NHE6 converge at the dendritic spine and similarly
compromise the recycling of AMPA receptors. Interestingly, pyr-
amidal and multipolar spiny neurons in cerebral cortex, amygdala
and other brain regions in lysosomal diseases with endosomal–
lysosomal GM2 ganglioside sequestration similar to that reported
here are also known to be characterized by abnormal (ectopic)
dendritogenesis, with the clinical syndromes in these disorders
also characterized by intellectual disability (Walkley, 1998, 2004b).
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The Slc9a6 knockout mouse used in this study appears to be a
useful model to reveal some of the pathogenic processes leading
to the human phenotypes caused by SLC9A6 mutation and to the
possible pathogenic cascade features underlying Angelman syn-
drome. Foremost, we documented that NHE6 deﬁciency leads to
an unexpected reduction in b-hexosaminidase and to the accumu-
lation of GM2 ganglioside and cholesterol in select neuronal popu-
lations, particularly those of the amygdala and hippocampus, and
to the formation of axonal spheroids and Purkinje cell degener-
ation in the cerebellum. Both these cellular pathological features
are reminiscent of those observed in primary lysosomal disorders
and suggest that the SLC9A6 mutations may be causing a here-
tofore unrecognized lysosomal storage disease.
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